A drug that provides temporary coronavirus immunity started human trials

$%name A drug that provides temporary coronavirus immunity started human trials by Authcom, Nova Scotia\s Internet and Computing Solutions Provider in Kentville, Annapolis Valley$

Companies working on brand new coronavirus drugs meant to treat COVID-19 and provide limited immunity are approaching human trials.
Monoclonal antibodies are artificially grown antibodies based on the ones the immune system develops when fighting off the coronavirus infection.
Eli Lilly is the first pharmaceutical company to have started human testing, with the Phase 1 drug trial already underway at several US hospitals.

The coronavirus epicenter moved from China to Europe to the US and then South America in a matter of months. As some outbreaks die down following successful tactics meant to flatten the curve, others flare up. And even as the number of new coronavirus cases drops in some regions, the risk of further outbreaks doesn’t disappear. We’ll still have to avoid crowds, wear masks, and wash our hands often throughout the day for the foreseeable future, and that’s because anybody can be infected.

The good news is that we’ve come a long way when it comes to treating COVID-19. Some of the meds that had been developed to treat other diseases work against the novel coronavirus as well, and vaccines are already showing plenty of promise. On top of that, researchers around the world are studying a brand new type of drug that’s been engineered specifically to fight off the COVID-19 infection. The first human trial for this type of medicine has already started, and the treatment could be available to patients long before vaccines are ready.

Continue reading…

Today’s Top Deals

Trending Right Now:

A drug that provides temporary coronavirus immunity started human trials originally appeared on BGR.com on Mon, 1 Jun 2020 at 15:14:49 EDT. Please see our terms for use of feeds.